Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal Product by Jonas Pielenhofer, Sophie Luise Meiser, Karsten Gogoll, Anna-Maria Ciciliani, Mark Denny, Michael Klak, Berenice M. Lang, Petra Staubach, Stephan Grabbe, Hansjörg Schild, Markus P. Radsak, Hilde Spahn-Langguth, Peter Langguth

Get full text

Tumor-infiltrating CCR2+ inflammatory monocytes counteract specific immunotherapy by Joschka Bartneck, Ann-Kathrin Hartmann, Lara Stein, Danielle Arnold-Schild, Matthias Klein, Michael Stassen, Federico Marini, Jonas Pielenhofer, Sophie Luise Meiser, Peter Langguth, Matthias Mack, Sabine Muth, Hans-Christian Probst, Hansjörg Schild, Markus Philipp Radsak

Get full text

Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejection by Ann-Kathrin Hartmann, Joschka Bartneck, Jonas Pielenhofer, Sophie Luise Meiser, Danielle Arnold-Schild, Matthias Klein, Matthias Klein, Michael Stassen, Michael Stassen, Hansjörg Schild, Hansjörg Schild, Hansjörg Schild, Sabine Muth, Sabine Muth, Hans Christian Probst, Hans Christian Probst, Peter Langguth, Peter Langguth, Stephan Grabbe, Stephan Grabbe, Markus P. Radsak, Markus P. Radsak, Markus P. Radsak

Get full text